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In 2014, the 3-year etonogestrel (ENG) subdermal contraceptive 
implant (Implanon NXT) became available in South Africa (SA). Over 
80 000 implants have been inserted to date in Western Cape Province, 
and over 800 000 nationally.[1] High-income country data indicate that 
the estimated non-palpable (and therefore difficult to remove) implant 
rate is 1.5 - 3%.[2] To meet the need for difficult removals, a specialist 
clinic was established 2 years ago at New Somerset Hospital in Cape 
Town and has since seen >300 patients.[3] Two patients with migrated 
implants have been referred to the clinic. We describe these two cases 
of implant migration from southern Africa.
Case reports
Case 1. Contraceptive implant cephalic vein migration 
to a site just anterior to the glenohumeral joint
A 32-year-old woman presented to her local community clinic for 
removal of an expired ENG implant and was referred to our clinic 
because the implant was impalpable. The implant had been inserted 
immediately postpartum into the left upper arm at a regional 
hospital 3 years previously. She reported no adverse effects, and 
that the implant had never been palpable. She reported no pain, 
swelling, varicosities or shortness of breath. The findings on physical 
examination were normal except for a body mass index of 39 kg/m2. 
A clear skin marking showed the original insertion site, incorrectly 
situated on the far lateral aspect of the upper arm. The implant was 
not palpable and could not be located via ultrasound, so a radiograph 
was taken.
The radiograph revealed a linear foreign body just above the 
glenohumeral joint in the area of the deltopectoral groove (Fig.  1). 
The image was compatible with a radio-opaque ENG implant. 
Surgical removal of the implant under general anaesthesia was 
performed on the same day by two of the authors. The patient was 
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The first difficult contraceptive implant removals clinic in sub-Saharan Africa was started 2 years ago at New Somerset Hospital in Cape 
Town, South Africa, and has seen two cases of implant migration. We report these cases here. The first was a case of fascial migration and 
the second one of migration via the cephalic vein, both to a site just anterior to the glenohumeral joint. Both implants were removed without 
complications. Even with correct insertion technique, migrations can occur. Healthcare providers need to know how to manage difficult 
removals, and how to access and refer to difficult removals services when necessary. These services must therefore be available in all settings 
where implants are offered, to ensure access to rights-based family planning services for all women in southern Africa.
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Fig. 1. Case 1. Radiograph of left upper arm demonstrating implant location 
above the glenohumeral joint, in the deltopectoral groove (arrow indicates 
tip of implant).
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cleaned and draped in the beach-chair position, and given 2 g of 
intravenous cefazolin preoperatively. An X-ray unit with a C-arm 
was used intraoperatively to locate the implant (lying anterior to the 
left shoulder) and guide incision (Fig. 2). A 6 cm incision was made 
over the deltopectoral groove, directly over the implant; the implant 
was located with blunt dissection and was found superficially in the 
deltopectoral groove. Careful dissection revealed that it was within the 
cephalic vein. The vein, which was sclerosed around the implant, was 
mobilised and ligated proximal and distal to the implant. The implant 
was then removed (Fig. 3). The minimal intraoperative bleeding was 
controlled with electrocautery. The wound was washed and closed 
with Vicryl 2/0 and subcutaneous Monocryl 3/0 sutures, and dressed 
in sterile fashion. Postoperatively, the patient was mobilised without 
restriction. We suspect lateral and deep (not subdermal) insertion 
into the cephalic vein as the mechanism of migration.
Case 2. Contraceptive implant migration along tissue 
plane, probably due to weight loss
A 28-year-old woman was referred to the difficult removals clinic 
from a community clinic after failed removal of a palpable but 
Fig. 2. Case 1. Intraoperative radiograph showing an etonogestrel implant 
lying anterior to the left shoulder (arrow indicates tip of implant).
Fig. 3. A 6 cm incision through which an etonogestrel implant was found 
and removed from the deltopectoral groove within the cephalic vein.
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Fig. 4. Case 2. Location and removal of an etonogestrel implant that 
superficially migrated to the anterior glenohumeral joint. In panel A, the small 
arrow points to the healing incision through which a general practitioner had 
attempted removal, the circle marks the original insertion site, and the line 
indicates location of the implant identified via ultrasound at the referral clinic. 
B - D show removal of the implant by grasping its midpoint with modified 
vasectomy clamps and pulling it up through a small incision.
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migrated ENG implant. The implant had been inserted 6 months 
previously at a community clinic. The patient wanted it removed 
because of the notable migration from the place of insertion. She 
reported that it had moved to her right shoulder region gradually, 
over time. On examination, there was a clear skin marking showing 
the original insertion site (Fig. 4 A, area marked with circle on skin), 
which was situated over the short head of the biceps muscle on the right 
upper arm. The SA National Department of Health’s 2014 training 
recommendation was for ENG implant insertion over the head of 
the biceps muscle, in the non-dominant arm (South African Training 
of Trainers Session on Insertions and Removals of Contraceptive 
Implants, February 2014, Cape Town, SA – unpublished; and as 
described in Guillebaud[4]). The implant was easily palpable over the 
glenohumeral joint, and removal had therefore been attempted in 
the community clinic by the general practitioner, without imaging. 
However, the attempt had failed, and the patient was referred. At the 
difficult removals clinic, the location was confirmed via ultrasound 
and marked with a line (Fig. 4 A, linear marking). A local anaesthetic, 
Xylotox 1.8 ml, was given over the middle of the implant. A small 
skin incision was made with a No. 11 blade. The implant was grasped 
with a modified vasectomy clamp at the midpoint of the implant, and 
elevated to the surface of the skin (Fig. 4, B and C). The capsule was 
incised and the implant was easily removed (Fig. 4 D). No skin sutures 
were required, and the incision was closed with SteriStrips and an 
Opsite Transparent Adhesive Film Dressing. Although the insertion 
site and depth were correct according to SA guidance at the time and 
the implant had been palpable ever since insertion, the patient had lost 
a significant amount of weight (8.5 kg in 6 months). We hypothesise 
that weight loss had propagated migration of the implant along the 
tissue plane of the biceps muscle.
Comment
Poor insertion technique, usually too deep or at an incorrect site,[3,5] 
often results in implants being difficult to remove, as well as in their 
migration.[6] However, even with correct insertion, implant migration 
is still possible, and substantially migrated implants often require 
specialist services for safe and effective removal. Services for difficult 
removals need to be established in all settings where contraceptive 
implants are offered, including in low- and middle-income countries, 
where in some settings removal training and services have lagged 
behind the tremendous upscaling of insertion services in recent 
years.[1,7,8] Community healthcare providers need to know how to 
approach difficult removals and where and when to refer if they are 
unable to complete the removals themselves.[3] Without availability of 
and easy client access to safe and effective implant removal services, 
quality, rights-based family planning programmes are compromised. 
Guaranteeing easy access to quality removal services, including for 
difficult and migrated implants, is essential in order for women 
to truly choose in a fully informed way among the full range of 
reversible modern contraceptive methods.
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